Cargando…

Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018

BACKGROUND: The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany...

Descripción completa

Detalles Bibliográficos
Autores principales: Guggenbühl Noller, Jessica Michelle, Froeschl, Guenter, Eisermann, Philip, Jochum, Johannes, Theuring, Stefanie, Reiter-Owona, Ingrid, Bissinger, Alfred Lennart, Hoelscher, Michael, Bakuli, Abhishek, von Sonnenburg, Franz-Josef Falkner, Rothe, Camilla, Bretzel, Gisela, Albajar-Viñas, Pedro, Grout, Lise, Pritsch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713040/
https://www.ncbi.nlm.nih.gov/pubmed/33272201
http://dx.doi.org/10.1186/s12879-020-05600-8
_version_ 1783618503675215872
author Guggenbühl Noller, Jessica Michelle
Froeschl, Guenter
Eisermann, Philip
Jochum, Johannes
Theuring, Stefanie
Reiter-Owona, Ingrid
Bissinger, Alfred Lennart
Hoelscher, Michael
Bakuli, Abhishek
von Sonnenburg, Franz-Josef Falkner
Rothe, Camilla
Bretzel, Gisela
Albajar-Viñas, Pedro
Grout, Lise
Pritsch, Michael
author_facet Guggenbühl Noller, Jessica Michelle
Froeschl, Guenter
Eisermann, Philip
Jochum, Johannes
Theuring, Stefanie
Reiter-Owona, Ingrid
Bissinger, Alfred Lennart
Hoelscher, Michael
Bakuli, Abhishek
von Sonnenburg, Franz-Josef Falkner
Rothe, Camilla
Bretzel, Gisela
Albajar-Viñas, Pedro
Grout, Lise
Pritsch, Michael
author_sort Guggenbühl Noller, Jessica Michelle
collection PubMed
description BACKGROUND: The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed. METHODS: German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000–2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires. RESULTS: Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Centres in Hamburg and Munich offered two independent serological tests to confirm the CD diagnosis, as recommended by WHO during the entire time period 2000–2018. Overall, a total of n = 10,728 independent tests involving n = 5991 individuals were identified with a progressive increase in testing rates over time, only n = 130 (16.0%) of the tested individuals with known nationality came from CD endemic countries. Of all test units conducted at the included institutes, a total of n = 347/10,728 (3.2%) tests on CD were positive, of which n = 200/347 (57.6%) were ELISA, n = 133/347 (38.3%) IFT, n = 10/347 (2.9%) PCR, and n = 4/347 (1.2%) RDT. Of the n = 5991 individuals only n = 81 (1.4%) with chronic infection were identified, n = 52 females and n = 28 males. Additional clinical information could only be collected from n = 47. CONCLUSION: The results of this study give insight into the deployment of screening, detection, diagnosis, and treatment of T. cruzi over the last two decades in Germany and existing deficits therein; the creation of guidelines for Germany could be a step forward to improve the existing gaps. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05600-8.
format Online
Article
Text
id pubmed-7713040
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77130402020-12-03 Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018 Guggenbühl Noller, Jessica Michelle Froeschl, Guenter Eisermann, Philip Jochum, Johannes Theuring, Stefanie Reiter-Owona, Ingrid Bissinger, Alfred Lennart Hoelscher, Michael Bakuli, Abhishek von Sonnenburg, Franz-Josef Falkner Rothe, Camilla Bretzel, Gisela Albajar-Viñas, Pedro Grout, Lise Pritsch, Michael BMC Infect Dis Research Article BACKGROUND: The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed. METHODS: German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000–2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires. RESULTS: Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Centres in Hamburg and Munich offered two independent serological tests to confirm the CD diagnosis, as recommended by WHO during the entire time period 2000–2018. Overall, a total of n = 10,728 independent tests involving n = 5991 individuals were identified with a progressive increase in testing rates over time, only n = 130 (16.0%) of the tested individuals with known nationality came from CD endemic countries. Of all test units conducted at the included institutes, a total of n = 347/10,728 (3.2%) tests on CD were positive, of which n = 200/347 (57.6%) were ELISA, n = 133/347 (38.3%) IFT, n = 10/347 (2.9%) PCR, and n = 4/347 (1.2%) RDT. Of the n = 5991 individuals only n = 81 (1.4%) with chronic infection were identified, n = 52 females and n = 28 males. Additional clinical information could only be collected from n = 47. CONCLUSION: The results of this study give insight into the deployment of screening, detection, diagnosis, and treatment of T. cruzi over the last two decades in Germany and existing deficits therein; the creation of guidelines for Germany could be a step forward to improve the existing gaps. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05600-8. BioMed Central 2020-12-03 /pmc/articles/PMC7713040/ /pubmed/33272201 http://dx.doi.org/10.1186/s12879-020-05600-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Guggenbühl Noller, Jessica Michelle
Froeschl, Guenter
Eisermann, Philip
Jochum, Johannes
Theuring, Stefanie
Reiter-Owona, Ingrid
Bissinger, Alfred Lennart
Hoelscher, Michael
Bakuli, Abhishek
von Sonnenburg, Franz-Josef Falkner
Rothe, Camilla
Bretzel, Gisela
Albajar-Viñas, Pedro
Grout, Lise
Pritsch, Michael
Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title_full Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title_fullStr Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title_full_unstemmed Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title_short Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
title_sort describing nearly two decades of chagas disease in germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of trypanosoma cruzi infection from 2000 – 2018
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713040/
https://www.ncbi.nlm.nih.gov/pubmed/33272201
http://dx.doi.org/10.1186/s12879-020-05600-8
work_keys_str_mv AT guggenbuhlnollerjessicamichelle describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT froeschlguenter describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT eisermannphilip describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT jochumjohannes describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT theuringstefanie describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT reiterowonaingrid describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT bissingeralfredlennart describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT hoelschermichael describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT bakuliabhishek describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT vonsonnenburgfranzjoseffalkner describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT rothecamilla describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT bretzelgisela describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT albajarvinaspedro describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT groutlise describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018
AT pritschmichael describingnearlytwodecadesofchagasdiseaseingermanyandthelessonslearnedaretrospectivestudyonscreeningdetectiondiagnosisandtreatmentoftrypanosomacruziinfectionfrom20002018